Infantile Marfan syndrome in a Korean tertiary referral center

Yeon Jeong Seo, Ko Eun Lee, Gi Beom Kim, Bo Sang Kwon, Eunjung Bae, Chung Il Noh

Research output: Contribution to journalArticle

Abstract

Purpose: Infantile Marfan syndrome (MFS) is a rare congenital inheritable connective tissue disorder with poor prognosis. This study aimed to evaluate the cardiovascular manifestations and overall prognosis of infantile MFS diagnosed in a tertiary referral center in Korea. Methods: Eight patients diagnosed with infantile MFS between 2004 and 2014 were retrospectively evaluated. Results: Their median age at the time of diagnosis was 2.5 months (range, 0–20 months). The median follow-up period was 25.5 months (range, 0–94 months). The median length at birth was 50.0 cm (range, 48–53 cm); however, height became more prominent over time, and the patients were taller than the 97th percentile at the time of the study. None of the patients had any relevant family history. Four of the 5 patients who underwent DNA sequencing had a fibrillin 1 gene mutation. All the patients with echocardiographic data of the aortic root had a z score of >2. All had mitral and tricuspid valve prolapse, and various degrees of mitral and tricuspid regurgitation. Five patients underwent open-heart surgery, including mitral valve replacement, of whom two required multiple operations. The median age at mitral valve replacement was 28.5 months (range, 5–69 months). Seven patients showed congestive heart failure before surgery or during follow-up, and required multiple anti-heart failure medications. Four patients died of heart failure at a median age of 12 months. Conclusion: The prognosis of infantile MFS is poor; thus, early diagnosis and timely cautious treatment are essential to prevent further morbidity and mortality.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalKorean Journal of Pediatrics
Volume59
Issue number2
DOIs
StatePublished - 1 Feb 2016

Fingerprint

Marfan Syndrome
Tertiary Care Centers
Heart Failure
Mitral Valve
Tricuspid Valve Prolapse
Tricuspid Valve Insufficiency
Mitral Valve Prolapse
Time and Motion Studies
Mitral Valve Insufficiency
Korea
DNA Sequence Analysis
Connective Tissue
Thoracic Surgery
Early Diagnosis
Parturition
Morbidity
Mutation
Mortality

Keywords

  • Marfan syndrome
  • Mitral valve insufficiency
  • Newborn infant

Cite this

Seo, Yeon Jeong ; Lee, Ko Eun ; Kim, Gi Beom ; Kwon, Bo Sang ; Bae, Eunjung ; Noh, Chung Il. / Infantile Marfan syndrome in a Korean tertiary referral center. In: Korean Journal of Pediatrics. 2016 ; Vol. 59, No. 2. pp. 59-64.
@article{aae9057aae3143a7b6d746d58b01f73b,
title = "Infantile Marfan syndrome in a Korean tertiary referral center",
abstract = "Purpose: Infantile Marfan syndrome (MFS) is a rare congenital inheritable connective tissue disorder with poor prognosis. This study aimed to evaluate the cardiovascular manifestations and overall prognosis of infantile MFS diagnosed in a tertiary referral center in Korea. Methods: Eight patients diagnosed with infantile MFS between 2004 and 2014 were retrospectively evaluated. Results: Their median age at the time of diagnosis was 2.5 months (range, 0–20 months). The median follow-up period was 25.5 months (range, 0–94 months). The median length at birth was 50.0 cm (range, 48–53 cm); however, height became more prominent over time, and the patients were taller than the 97th percentile at the time of the study. None of the patients had any relevant family history. Four of the 5 patients who underwent DNA sequencing had a fibrillin 1 gene mutation. All the patients with echocardiographic data of the aortic root had a z score of >2. All had mitral and tricuspid valve prolapse, and various degrees of mitral and tricuspid regurgitation. Five patients underwent open-heart surgery, including mitral valve replacement, of whom two required multiple operations. The median age at mitral valve replacement was 28.5 months (range, 5–69 months). Seven patients showed congestive heart failure before surgery or during follow-up, and required multiple anti-heart failure medications. Four patients died of heart failure at a median age of 12 months. Conclusion: The prognosis of infantile MFS is poor; thus, early diagnosis and timely cautious treatment are essential to prevent further morbidity and mortality.",
keywords = "Marfan syndrome, Mitral valve insufficiency, Newborn infant",
author = "Seo, {Yeon Jeong} and Lee, {Ko Eun} and Kim, {Gi Beom} and Kwon, {Bo Sang} and Eunjung Bae and Noh, {Chung Il}",
year = "2016",
month = "2",
day = "1",
doi = "10.3345/kjp.2016.59.2.59",
language = "English",
volume = "59",
pages = "59--64",
journal = "Korean Journal of Pediatrics",
issn = "1738-1061",
publisher = "Korean Pediatric Society",
number = "2",

}

Infantile Marfan syndrome in a Korean tertiary referral center. / Seo, Yeon Jeong; Lee, Ko Eun; Kim, Gi Beom; Kwon, Bo Sang; Bae, Eunjung; Noh, Chung Il.

In: Korean Journal of Pediatrics, Vol. 59, No. 2, 01.02.2016, p. 59-64.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Infantile Marfan syndrome in a Korean tertiary referral center

AU - Seo, Yeon Jeong

AU - Lee, Ko Eun

AU - Kim, Gi Beom

AU - Kwon, Bo Sang

AU - Bae, Eunjung

AU - Noh, Chung Il

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Purpose: Infantile Marfan syndrome (MFS) is a rare congenital inheritable connective tissue disorder with poor prognosis. This study aimed to evaluate the cardiovascular manifestations and overall prognosis of infantile MFS diagnosed in a tertiary referral center in Korea. Methods: Eight patients diagnosed with infantile MFS between 2004 and 2014 were retrospectively evaluated. Results: Their median age at the time of diagnosis was 2.5 months (range, 0–20 months). The median follow-up period was 25.5 months (range, 0–94 months). The median length at birth was 50.0 cm (range, 48–53 cm); however, height became more prominent over time, and the patients were taller than the 97th percentile at the time of the study. None of the patients had any relevant family history. Four of the 5 patients who underwent DNA sequencing had a fibrillin 1 gene mutation. All the patients with echocardiographic data of the aortic root had a z score of >2. All had mitral and tricuspid valve prolapse, and various degrees of mitral and tricuspid regurgitation. Five patients underwent open-heart surgery, including mitral valve replacement, of whom two required multiple operations. The median age at mitral valve replacement was 28.5 months (range, 5–69 months). Seven patients showed congestive heart failure before surgery or during follow-up, and required multiple anti-heart failure medications. Four patients died of heart failure at a median age of 12 months. Conclusion: The prognosis of infantile MFS is poor; thus, early diagnosis and timely cautious treatment are essential to prevent further morbidity and mortality.

AB - Purpose: Infantile Marfan syndrome (MFS) is a rare congenital inheritable connective tissue disorder with poor prognosis. This study aimed to evaluate the cardiovascular manifestations and overall prognosis of infantile MFS diagnosed in a tertiary referral center in Korea. Methods: Eight patients diagnosed with infantile MFS between 2004 and 2014 were retrospectively evaluated. Results: Their median age at the time of diagnosis was 2.5 months (range, 0–20 months). The median follow-up period was 25.5 months (range, 0–94 months). The median length at birth was 50.0 cm (range, 48–53 cm); however, height became more prominent over time, and the patients were taller than the 97th percentile at the time of the study. None of the patients had any relevant family history. Four of the 5 patients who underwent DNA sequencing had a fibrillin 1 gene mutation. All the patients with echocardiographic data of the aortic root had a z score of >2. All had mitral and tricuspid valve prolapse, and various degrees of mitral and tricuspid regurgitation. Five patients underwent open-heart surgery, including mitral valve replacement, of whom two required multiple operations. The median age at mitral valve replacement was 28.5 months (range, 5–69 months). Seven patients showed congestive heart failure before surgery or during follow-up, and required multiple anti-heart failure medications. Four patients died of heart failure at a median age of 12 months. Conclusion: The prognosis of infantile MFS is poor; thus, early diagnosis and timely cautious treatment are essential to prevent further morbidity and mortality.

KW - Marfan syndrome

KW - Mitral valve insufficiency

KW - Newborn infant

UR - http://www.scopus.com/inward/record.url?scp=84958078805&partnerID=8YFLogxK

U2 - 10.3345/kjp.2016.59.2.59

DO - 10.3345/kjp.2016.59.2.59

M3 - Article

AN - SCOPUS:84958078805

VL - 59

SP - 59

EP - 64

JO - Korean Journal of Pediatrics

JF - Korean Journal of Pediatrics

SN - 1738-1061

IS - 2

ER -